4
Changes in Ownership
Vir Biotechnology, Inc. Filed Acc 0001209191-21-020165
EVP, Research & CSO sold 2,340 shares at $48.00 ($112,320)
- EVP, Research & CSO acquired 2,340 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Virgin Herbert EVP, Research & CSO | 2021-03-10 | Option exercise | +2,340 | $1.53 | $3,580 | 76,540 | D |
| Virgin Herbert EVP, Research & CSO | 2021-03-10 | Sale | −2,340 | $48.00 | $112,320 | 74,200 | D |
| Derivatives | |||||||
| Virgin Herbert EVP, Research & CSO | 2021-03-10 | Option exercise · Stock Option (Right to Buy) | −2,340 | 345,455 | D | ||
| Open-market sales · 2,340 sh · avg $48.00 · $112,320 | |||||||
Loading xslF345X03/doc4.xml…